CN100340284C - Jindan gallbladder stone dissolving capsule - Google Patents
Jindan gallbladder stone dissolving capsule Download PDFInfo
- Publication number
- CN100340284C CN100340284C CNB2005100430462A CN200510043046A CN100340284C CN 100340284 C CN100340284 C CN 100340284C CN B2005100430462 A CNB2005100430462 A CN B2005100430462A CN 200510043046 A CN200510043046 A CN 200510043046A CN 100340284 C CN100340284 C CN 100340284C
- Authority
- CN
- China
- Prior art keywords
- shares
- jindan
- radix
- gallbladder
- dissolving capsule
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a Jindan gallbladder stone dissolving capsule for curing gallbladder stone and gallstone, which belongs to medicinal preparations. The Jindan gallbladder stone dissolving capsule is prepared from the raw materials with shares by weight: 6 to 180 shares of longhairy antenoron herb, 6 to 15 shares of herba artemisiae capillaris, 10 to 20 shares of endothelium corneum gigeriae galli, 6 to 10 shares of bitter orange, 10 to 25 shares of red sage root, 10 to 25 shares of tangerine peel, 6 to 10 shares of nutgrass galingale rhizome, 10 to 30 shares of curcuma, 5 to 10 shares of licorice, 10 to 60 shares of clematis root, 5 to 15 shares of bear gall, 10 to 30 shares of herba pyrrosiae, 10 to 20 shares of rhubarb, 10 to 15 shares of mirabilite, 10 to 15 shares of raw haw, 6 to 10 shares of bupleurum root, 10 to 20 shares of hemlock parsley and 10 to 20 shares of Chinese date. Clinical observation results show that the total effective rate of the Jindan gallbladder stone dissolving capsule is 95%, and the cure rate is 67.50%; the present Jindan gallbladder stone dissolving capsule has obvious curative effects which are superior to those of German gallbladder removing medicines of a contrast group.
Description
Technical field
The invention belongs to a kind of pharmaceutical product, particularly a kind of Jindan gallbladder stone dissolving capsule that is used for the treatment of liver and bile stone disease.
Background technology
Cholelithiasis is surgical common disease and frequently-occurring disease, is commonly considered as due to cholestasis, biliary tract antibacterial and the parasitic infection, and wherein the cholesterol imbalance also is a principal element.The removing means of generally taking to perform the operation are at present treated more, and not only patient is painful big, and medical expense is quite high, has increased the weight of patient's burden.The litholytic Chinese medicine that is used for that is seen in report also has, but all has the thorough inadequately and slow drawback of lithodialysis.
(patent No.: 01128739.X), although also liver and bile stone is had therapeutical effect preferably, it is complicated that its prescription is disliked slightly, and the compatibility reasonability is not good enough at the Litholysizing bear gall powder of calendar year 2001 application for one of inventor.
Summary of the invention
The present invention seeks on the basis of the aforementioned invention of inventor, prescription to be deleted and adjusted, further optimize and provide a kind of by the oral pure Chinese medicinal preparation that dissolves liver and bile stone.
Jindan gallbladder stone dissolving capsule of the present invention is to be made by the raw material of following weight portion:
Herba Lysimachiae 6-180, Herba Artemisiae Scopariae 6-15, Endothelium Corneum Gigeriae Galli 10-20, Fructus Aurantii 6-10, Radix Salviae Miltiorrhizae 10-25, Pericarpium Citri Reticulatae 10-25, Rhizoma Cyperi 6-10, Radix Curcumae 10-30, Radix Glycyrrhizae 5-10, Radix Clematidis 10-60, Fel Ursi 5-15, Folium Pyrrosiae 10-30, Radix Et Rhizoma Rhei 10-20, Natrii Sulfas 10-15, Fructus Crataegi 10-15, Radix Bupleuri 6-10, Rhizoma Chuanxiong 10-20, Fructus Jujubae 10-20.
The preferential prescription of recommending of the present invention is:
Herba Lysimachiae 50-120, Herba Artemisiae Scopariae 8-12, Endothelium Corneum Gigeriae Galli 13-17, Fructus Aurantii 8-12, Radix Salviae Miltiorrhizae 17-22, Pericarpium Citri Reticulatae 17-22, Rhizoma Cyperi 8-12, Radix Curcumae 18-25, Radix Glycyrrhizae 5-10, Radix Clematidis 30-40, Fel Ursi 5-15, Folium Pyrrosiae 18-25, Radix Et Rhizoma Rhei 15-18, Natrii Sulfas 10-15, Fructus Crataegi 10-15, Radix Bupleuri 6-10, Rhizoma Chuanxiong 15-18, Fructus Jujubae 10-20.
With encapsulated behind above medicine levigation, sieve 100 orders, mixing, the disinfection by ultraviolet light, make powder, honeyed pill or the watered pill and all can.
The effect that the present invention has the gentle stomach of depressed liver-energy dispersing and QI regulating, anti-inflammatory and choleretic, spleen invigorating, the stasis of blood of reducing phlegm, melts liver and bile stone is used for residual stone, choledocholithiasis, gallbladder hydrops after liver and bile stone, acute and chronic cholecystitis, the operation, significant curative effect is arranged.The characteristics that have no wound, no pain, take medicine conveniently, have no side effect, lithagogue rate are high.
The preparation that the inventor utilizes the present invention to fill a prescription is treated cholelithiasis 120 examples altogether, calculus 81 examples (accounting for 67.50%) that all disappear, and calculus is dwindled 33 examples (accounting for 27.5%), and calculus does not obviously reduce 6 examples (accounting for 5%).Total effective rate reaches 95%.The present invention simultaneously and German medicine AIHUO DANTONG are made 102 routine contrast tests and are shown that also the present invention has significant difference than it.
The specific embodiment
Embodiment 1: with following raw material of Chinese medicine through screening, clean and pulverize the back and cross 300 mesh sieves, encapsulatedly promptly become preparation of the present invention.
Herba Lysimachiae 6, Herba Artemisiae Scopariae 15, Endothelium Corneum Gigeriae Galli 10, Fructus Aurantii 10, Radix Salviae Miltiorrhizae 10, Pericarpium Citri Reticulatae 25, Rhizoma Cyperi 6, Radix Curcumae 30, Radix Glycyrrhizae 5, Radix Clematidis 60, Fel Ursi 5, Folium Pyrrosiae 30, Radix Et Rhizoma Rhei 10, Natrii Sulfas 15, Fructus Crataegi 10, Radix Bupleuri 10, Rhizoma Chuanxiong 10, Fructus Jujubae 20.
Embodiment 2: following raw material of Chinese medicine is crossed 300 mesh sieves through screening, cleaning with after pulverizing, and making honeyed pill promptly becomes preparation of the present invention.
Herba Lysimachiae 180, Herba Artemisiae Scopariae 6, Endothelium Corneum Gigeriae Galli 20, Fructus Aurantii 6, Radix Salviae Miltiorrhizae 25, Pericarpium Citri Reticulatae 10, Rhizoma Cyperi 10, Radix Curcumae 10, Radix Glycyrrhizae 10, Radix Clematidis 10, Fel Ursi 5, Folium Pyrrosiae 30, Radix Et Rhizoma Rhei 20, Natrii Sulfas 10, Fructus Crataegi 15, Radix Bupleuri 6, Rhizoma Chuanxiong 20, Fructus Jujubae 10.
Embodiment 3: with following raw material of Chinese medicine through screening, clean and pulverize, add water and make oral concentrated solution and promptly become preparation of the present invention.
Herba Lysimachiae 100, Herba Artemisiae Scopariae 9, Endothelium Corneum Gigeriae Galli 16, Fructus Aurantii 8, Radix Salviae Miltiorrhizae 18, Pericarpium Citri Reticulatae 18, Rhizoma Cyperi 8, Radix Curcumae 21, Radix Glycyrrhizae 7, Radix Clematidis 30, Fel Ursi 12, Folium Pyrrosiae 21, Radix Et Rhizoma Rhei 16, Natrii Sulfas 13, Fructus Crataegi 12, Radix Bupleuri 8, Rhizoma Chuanxiong 15, Fructus Jujubae 15.
The Jindan gallbladder stone dissolving capsule treatment cholelithiasis 120 routine clinical reports of the present invention of utilizing the foregoing description to make are as follows:
One, clinical data
1, the patient that 120 routine patients treated for special outpatient clinic is organized in treatment, male's 52 examples, women's 68 examples, age 25-50 year 72 examples, patient's 48 examples more than 50 years old, non-evident sympton or only show general dyspepsia person's 96 examples usually has stomachache, feels sick, symptom 24 people such as vomiting, and all patients are all through ultrasound diagnosis more than 2 times or remake X line, CT, gallbladder examination and make a definite diagnosis.
2, two groups of sexes of patient of making a definite diagnosis from the treatment group of matched group 102 patients, age, the course of disease, the state of an illness, cardinal symptom, professional aspect there was no significant difference relatively has comparability.
Two, Therapeutic Method
1, treatment group: according to actual capsule or the pill made of patient, medication dose is grasped flexibly according to patient age, body constitution by prescription of the present invention, every day three times, one after each meal 6 grams.30 days is a course of treatment, and be an observation period three courses of treatment.
2, treatment group: take German AIHUO DANTONG every day, every day 3 times, one time 2.
Three, therapeutic effect
1, criterion standard: adopt the whole nation unified diagnosis and curative effect judging standard.
Cure: sings and symptoms disappears, and imaging examination (B ultrasonic, PTC, ERCP, biliary tract vein or peroral contrast must have wherein 2 kinds of inspection methods) calculus disappears; Produce effects: sings and symptoms alleviates, and the imaging examination calculus has obviously and reduces, reach more than 1/2, or the calculus person of diminishing; Invalid: symptom and body no change, the imaging examination calculus does not have the changer.
2, two groups of total effectses relatively treatment organize 120 examples, cure 81 (accounting for 67.50%), produce effects 33 examples (accounting for 27.5%), invalid 6 examples (accounting for 5%), total effective rate reaches 95%; Matched group 102 examples are cured 15 examples (accounting for 14.71%), produce effects 36 examples (accounting for 35.29%), invalid 51 examples (accounting for 50.00%), total effective rate 50%.Two groups of cure rate differences have significance (ρ<0.05=.
Four, brief summary
1, clinical observation result shows, the Jindan gallbladder stone dissolving capsule total effective rate is 95%, and cure rate is 67.50%, evident in efficacy, obviously be better than matched group medicine Germany DANTONG.
2, Jindan gallbladder stone dissolving capsule is formed with Chinese herbal medicine, mineral and animal raw materials, have depressed liver-energy dispersing and QI regulating, anti-inflammatory and choleretic, spleen invigorating gentle stomach, the stasis of blood of reducing phlegm, melt the effect of liver and bile stone, the full reasonable recipe of visiting, compatibility is proper, thereby cholelithiasis is had therapeutical effect preferably.
Claims (1)
1, a kind of Jindan gallbladder stone dissolving capsule for the treatment of liver and bile stone disease is characterized in that being made by the raw material of following weight portion:
Herba Lysimachiae 6-180, Herba Artemisiae Scopariae 6-15, Endothelium Corneum Gigeriae Galli 10-20, Fructus Aurantii 6-10, Radix Salviae Miltiorrhizae 10-25, Pericarpium Citri Reticulatae 10-25, Rhizoma Cyperi 6-10, Radix Curcumae 10-30, Radix Glycyrrhizae 5-10, Radix Clematidis 10-60, Fel Ursi 5-15, Folium Pyrrosiae 10-30, Radix Et Rhizoma Rhei 10-20, Natrii Sulfas 10-15, Fructus Crataegi 10-15, Radix Bupleuri 6-10, Rhizoma Chuanxiong 10-20, Fructus Jujubae 10-20.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100430462A CN100340284C (en) | 2005-08-03 | 2005-08-03 | Jindan gallbladder stone dissolving capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100430462A CN100340284C (en) | 2005-08-03 | 2005-08-03 | Jindan gallbladder stone dissolving capsule |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1785403A CN1785403A (en) | 2006-06-14 |
CN100340284C true CN100340284C (en) | 2007-10-03 |
Family
ID=36783071
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100430462A Expired - Fee Related CN100340284C (en) | 2005-08-03 | 2005-08-03 | Jindan gallbladder stone dissolving capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100340284C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100571727C (en) * | 2005-09-05 | 2009-12-23 | 中国中医科学院中药研究所 | Direct lytic agent of a kind of Chinese medicine compound cholelithiasis and preparation method thereof |
CN103230570A (en) * | 2013-05-11 | 2013-08-07 | 亳州师范高等专科学校 | Chinese herbal medicine composition for treating calculus |
CN106620545A (en) * | 2017-03-09 | 2017-05-10 | 李耀宗 | Drug used for treating gallstones and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130219C (en) * | 2001-07-26 | 2003-12-10 | 王继平 | Litholysizing bear gall powder |
CN1593601A (en) * | 2004-07-12 | 2005-03-16 | 张成军 | Chinese medicinal composition for cholecystitis and preparing method thereof |
-
2005
- 2005-08-03 CN CNB2005100430462A patent/CN100340284C/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130219C (en) * | 2001-07-26 | 2003-12-10 | 王继平 | Litholysizing bear gall powder |
CN1593601A (en) * | 2004-07-12 | 2005-03-16 | 张成军 | Chinese medicinal composition for cholecystitis and preparing method thereof |
Non-Patent Citations (1)
Title |
---|
胆石病中医辨证论治进展 顾宏刚,钟逸斐,方邦江,《湖北中医学院学报》,第7卷第2期 2005 * |
Also Published As
Publication number | Publication date |
---|---|
CN1785403A (en) | 2006-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1130219C (en) | Litholysizing bear gall powder | |
CN101422530A (en) | Traditional Chinese medicine for treating upper right front-tooth pyretic toothache | |
CN100340284C (en) | Jindan gallbladder stone dissolving capsule | |
CN100444888C (en) | The Chinese herbal medicinal pills for treatment of hepatitis B and liver cancer | |
CN1172690C (en) | Chinese medicine powder for treating tetanic rachitis | |
CN1404854A (en) | Medicine for treating nosal inflammation | |
CN1745826A (en) | Chinese medicinal for treating heart disease | |
CN1067571C (en) | Chinese medicine capsule for treating lumbar and cervical protrusion | |
CN1193782C (en) | Medicament for treating lumbar and cervical vertebra pain | |
CN1186044C (en) | Chinese medicine 'lidandishi' for treating hepatobiliary calculus and cholecystitis | |
CN1559486A (en) | Health-care medicinal plaster used for preventing and curing discopathy, osteosis, ischialgia | |
CN1136899C (en) | Chinese medicine for treating mastoplasia | |
CN101057893A (en) | Traditional Chinese medicine for treating osteoproliferation, rheumatoid and rheumatic arthritis and sciatica | |
CN1218684A (en) | Capsule for expelling stone | |
CN101152300A (en) | Traditional Chinese medicine for treating stasis type intestinal obstruction | |
CN1235635C (en) | Medicine for treating osteosis | |
CN1228321A (en) | Drug for curing stone of urinary system | |
CN1814254A (en) | Chinese medicine for treating B-type hepatitis | |
CN1183918C (en) | Medicine for curing protrution of intervetebral disc and its preparing method | |
CN1223365C (en) | Menstruation-regulating and pregnancy-promoting Chinese medicine and its prepn | |
CN1175852C (en) | Medicine for treating hyperosteogeny | |
CN1318402A (en) | Medicine for traumatic fracture pain | |
CN102018851B (en) | Nine-ingredient papaya numbness-relieving capsules and preparation method thereof | |
CN1275391A (en) | Oral proprietary medicine for normalizing secretion and removing urinary calcultus | |
CN1593588A (en) | Quick-acting gingival blood capsule formula for treating gingival bleeding and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071003 Termination date: 20100803 |